Keystone Bio
St. Louis, US · Founded 2018 · Delaware corporation
Founders & leadership
DS
Daniel SindelarNamed on SEC filing
PN
Peter NaraNamed on SEC filing
MP
Marc PennNamed on SEC filing
DH
David HugleyNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2019
▶$5MraisedApr 2019 · 1 investors · BiotechnologyRule 506(c)
▶$5MraisedApr 2019 · 1 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Daniel SindelarExecutive Officer, Director
- Peter NaraDirector
- Marc PennDirector
- David HugleyDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $5M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Keystone Bio raised?
- Keystone Bio has disclosed $5M raised across 1 round.
- Where is Keystone Bio headquartered?
- Keystone Bio is headquartered in St. Louis, US.